Your browser doesn't support javascript.
loading
China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.
Qi, Changsong; Zhou, Ting; Bai, Yuezong; Chen, Hui; Yuan, Jiajia; Zhao, Feilong; Liu, Chang; Ma, Mingyang; Bei, Ting; Chen, Shiqing; Zhao, Xiaochen; Chen, Chunzhu; Shen, Lin.
Afiliação
  • Qi C; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhou T; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Bai Y; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Chen H; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Yuan J; Medical Affairs, 3D Medicines Inc., Shanghai, China.
  • Zhao F; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Liu C; Medical Affairs, 3D Medicines Inc., Shanghai, China.
  • Ma M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, China.
  • Bei T; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Chen S; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Zhao X; Medical Affairs, 3D Medicines Inc., Shanghai, China.
  • Chen C; Medical Affairs, 3D Medicines Inc., Shanghai, China.
  • Shen L; Medical Affairs, 3D Medicines Inc., Shanghai, China.
Int J Cancer ; 153(11): 1916-1927, 2023 12 01.
Article em En | MEDLINE | ID: mdl-36946696
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Tumoral Circulante / Neoplasias Gastrointestinais / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Tumoral Circulante / Neoplasias Gastrointestinais / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China